Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Filings indexed 518 across all filing types
Latest filing 2026-03-25 Regulatory Filings
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Sprawozdanie z działalności Scope Fluidics S.A. i GK Scope Fluidics S.A. za 2025 rok (podpis)
Regulatory Filings
2026-03-25 Polish
Jednostkowe sprawozdanie finansowe ScopeFluidics S.A. za 2025 rok (podpis)
Regulatory Filings
2026-03-25 Polish
Sprawozdanie z działalności Scope Fluidics S.A. i GK Scope Fluidics S.A. za 2025 rok
Regulatory Filings
2026-03-25 Polish
Jednostkowe sprawozdanie finansowe ScopeFluidics S.A. za 2025 rok
Regulatory Filings
2026-03-25 Polish
Zmiana terminu publikacji raportu rocznego - Content (PL)
Report Publication Announcement Classification · 87% confidence The document is a short announcement (406 characters) informing shareholders of a change in the publication date of the annual report rather than containing the report itself. It clearly states when the annual report will be published, fitting the definition of a Report Publication Announcement (RPA).
2026-03-23 Polish
Dopuszczenie rozszerzonego modelu finansowania istniejących i nowych spółek celowych wywodzących się ze Scope Discovery - Content (PL)
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from Scope Fluidics S.A. regarding a change in their financing strategy for subsidiary projects (Scope Discovery). It details a shift in the business model to allow external equity financing at the subsidiary level, which impacts the company's capital structure and ownership strategy. This does not fit into specific categories like '10-K' (annual report), 'CT' (transcript), or 'DIV' (dividend). It is a formal corporate disclosure regarding financing and capital structure strategy, which falls under the 'CAP' (Capital/Financing Update) category as it specifically addresses the 'Rozszerzony Model' (Extended Model) of financing.
2026-03-19 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.